Literature DB >> 23624295

Toll-like receptor 9 deficiency impacts sensory and motor behaviors.

Veronika Khariv1, Kevin Pang, Richard J Servatius, Brian T David, Matthew T Goodus, Kevin D Beck, Robert F Heary, Stella Elkabes.   

Abstract

Toll-like receptors (TLRs) mediate the induction of the innate immune system in response to pathogens, injury and disease. However, they also play non-immune roles and are expressed in the central nervous system (CNS) during prenatal and postnatal stages including adulthood. Little is known about their roles in the CNS in the absence of pathology. Several members of the TLR family have been implicated in the development of neural and cognitive function although the contribution of TLR9 to these processes has not been well defined. The current studies were undertaken to determine whether developmental TLR9 deficiency affects motor, sensory or cognitive functions. We report that TLR9 deficient (TLR9(-/-)) mice show a hyper-responsive sensory and motor phenotype compared to wild type (TLR9(+/+)) controls. This is indicated by hypersensitivity to thermal stimuli in the hot plate paw withdrawal test, enhanced motor-responsivity under anxious conditions in the open field test and greater sensorimotor reactivity in the acoustic startle response. Prepulse inhibition (PPI) of the acoustic startle response was also enhanced, which indicates abnormal sensorimotor gating. In addition, subtle, but significant, gait abnormalities were noted in the TLR9(-/-) mice on the horizontal balance beam test with higher foot slip numbers than TLR9(+/+) controls. In contrast, spatial learning and memory, assessed by the Morris water maze, was similar in the TLR9(-/-) and TLR9(+/+) mice. These findings support the notion that TLR9 is important for the appropriate development of sensory and motor behaviors.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23624295     DOI: 10.1016/j.bbi.2013.04.007

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  7 in total

Review 1.  Molecular and cellular mechanisms that initiate pain and itch.

Authors:  Jialie Luo; Jing Feng; Shenbin Liu; Edgar T Walters; Hongzhen Hu
Journal:  Cell Mol Life Sci       Date:  2015-04-18       Impact factor: 9.261

Review 2.  Innate immune responses regulate morphogenesis and degeneration: roles of Toll-like receptors and Sarm1 in neurons.

Authors:  Hsin-Yu Liu; Chiung-Ya Chen; Yi-Ping Hsueh
Journal:  Neurosci Bull       Date:  2014-07-04       Impact factor: 5.203

Review 3.  GABAAR α2-activated neuroimmune signal controls binge drinking and impulsivity through regulation of the CCL2/CX3CL1 balance.

Authors:  Laure Aurelian; Irina Balan
Journal:  Psychopharmacology (Berl)       Date:  2019-04-27       Impact factor: 4.530

4.  Association Between Magnetic Resonance Imaging-Based Spinal Morphometry and Sensorimotor Behavior in a Hemicontusion Model of Incomplete Cervical Spinal Cord Injury in Rats.

Authors:  Jyothsna Chitturi; Basavaraju G Sanganahalli; Peter Herman; Fahmeed Hyder; Li Ni; Stella Elkabes; Robert Heary; Sridhar S Kannurpatti
Journal:  Brain Connect       Date:  2020-10-29

Review 5.  Innate immunity at the crossroads of healthy brain maturation and neurodevelopmental disorders.

Authors:  Kristine E Zengeler; John R Lukens
Journal:  Nat Rev Immunol       Date:  2021-01-21       Impact factor: 108.555

6.  Endosomal TLR3, TLR7, and TLR8 control neuronal morphology through different transcriptional programs.

Authors:  Yun-Fen Hung; Chiung-Ya Chen; Yi-Chun Shih; Hsin-Yu Liu; Chiao-Ming Huang; Yi-Ping Hsueh
Journal:  J Cell Biol       Date:  2018-05-18       Impact factor: 10.539

7.  Astroglial TLR9 antagonism promotes chemotaxis and alternative activation of macrophages via modulation of astrocyte-derived signals: implications for spinal cord injury.

Authors:  Lun Li; Li Ni; Robert F Heary; Stella Elkabes
Journal:  J Neuroinflammation       Date:  2020-02-25       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.